Share-based Payment Arrangement, Expense of Peak Bio, Inc. from 31 Dec 2021 to 30 Sep 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Peak Bio, Inc. quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 31 Dec 2021 to 30 Sep 2024.
  • Peak Bio, Inc. Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2024 was $0, a 100% decline year-over-year.
  • Peak Bio, Inc. Share-based Payment Arrangement, Expense for the twelve months ending 30 Sep 2024 was $69,312, a 114% decline year-over-year.
  • Peak Bio, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $275,418, a 51% decline from 2022.
  • Peak Bio, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $560,060, a 11353% increase from 2021.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

Peak Bio, Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2024 $69,312 $0 -$76,795 -100% 01 Jul 2024 30 Sep 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 $7,483 $0 -$133,437 -100% 01 Apr 2024 30 Jun 2024 10-Q 23 Aug 2024 2024 Q2
Q1 2024 $140,920 $30,509 -$134,498 -82% 01 Jan 2024 31 Mar 2024 10-Q 23 Aug 2024 2024 Q1
Q4 2023 $275,418 $99,821 -$227,519 -178% 01 Oct 2023 31 Dec 2023 10-K 06 Aug 2024 2023 FY
Q3 2023 $502,937 $76,795 -$81,776 -52% 01 Jul 2023 30 Sep 2023 10-Q 12 Nov 2024 2024 Q3
Q2 2023 $584,713 $133,437 -$32,340 -20% 01 Apr 2023 30 Jun 2023 10-Q 23 Aug 2024 2024 Q2
Q1 2023 $617,053 $165,007 +$56,993 +53% 01 Jan 2023 31 Mar 2023 10-Q 23 Aug 2024 2024 Q1
Q4 2022 $560,060 $127,698 01 Oct 2022 31 Dec 2022 10-K 06 Aug 2024 2023 FY
Q3 2022 $158,571 01 Jul 2022 30 Sep 2022 10-Q 25 Jun 2024 2023 Q3
Q2 2022 $165,777 01 Apr 2022 30 Jun 2022 10-Q 18 Aug 2023 2023 Q2
Q1 2022 $108,014 01 Jan 2022 31 Mar 2022 10-Q 12 Jul 2023 2023 Q1

Peak Bio, Inc. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2023 $275,418 -$284,642 -51% 01 Jan 2023 31 Dec 2023 10-K 06 Aug 2024 2023 FY
2022 $560,060 +$555,170 +11353% 01 Jan 2022 31 Dec 2022 10-K 06 Aug 2024 2023 FY
2021 $4,890 01 Jan 2021 31 Dec 2021 10-K 29 Jun 2023 2022 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.